Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Koru Medical Systems Q3 2026 Results: Turns Profitable, Net Income $218K

KORU Medical Systems reported net revenues of $11.6 million for the quarter ended September 30, 2026, representing growth over the $10.4 million reported in the prior year period. The company achieved a net income of $0.2 million for the quarter, a significant improvement from the $0.8 million net loss in the same period of 2025.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue11.610.4
Gross profit7.56.3
Profit before tax0.2-0.8
Net income0.2-0.8
EPS (diluted, $ a share)$0.00$-0.02

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+11.2%
Gross margin65.2%
Operating margin1.6%
Source

10-Q filed with the SEC, NASDAQ: KRMD. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Koru Medical Systems, Inc.: key numbers

Share price
$3.49Close, Nov 17
Market cap
$151M
Shares outstanding
43.38MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Koru Medical Systems, Inc.

All →
4:07 PM ET Form 4
Insider Buying

Koru Medical Systems CTO Eric Schiller Buys $31K of Stock

Eric Schiller, CTO, bought 8,546 shares of Koru Medical Systems, Inc. at $3.63 a share, worth $31K in total on Nov 13, 2026. Shares held after the trade: 13,546 (+170.9%).

Value
$31K
Shares
8,546
Price
$3.63
Role
CTO
Holding change
+170.9%
Trade date
Nov 13, 2026
4:44 PM ET 8-K
Financial Results

Koru Medical Systems Financial Results

KORU Medical Systems reported Q3 2026 net revenues of $11.6 million, an 11% increase year-over-year, and achieved its second consecutive quarter of positive net income. The company revised its full-year 2026 revenue guidance to $48.0-$48.5 million and highlighted growth in domestic core revenues driven by higher pump and consumable volumes.

Term
Q3 2026

“Total Revenue of $11.6 million represents another quarter of consistent above-market growth for KORU, driven by our recurring patient base. We also delivered positive net income and adjusted EBITDA for the second consecutive quarter, demonstrating the scalability of our business model.”

Adam Kalbermatten, President and CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.